Search Medical Condition
Please enter condition
Please choose location from dropdown

Autism Clinical Trials

A listing of Autism medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (269) clinical trials

This study will evaluate the efficacy and safety of ZYN002, a clear cannabidiol (CBD) gel that can be applied to the skin (called transdermal application) twice a day for the treatment of behavioral symptoms of Fragile X syndrome (FXS).  

Phase

Purpose of the study: The Children’s Research Unit at Albert Einstein College of Medicine of Yeshiva University are currently recruiting participants for a research study that examines whether multisensory integration (the brain’s processing of information from different senses) is impaired in people with autism. Protocol summary: Information from the various ...

Phase N/A

The purpose of the study is to assess the efficacy of two highly requested treatments for children with autism spectrum disorder, both of which are directed at increasing functional skills and reducing maladaptive sensory behaviors: occupational therapy using sensory strategies for decreasing sensory dysfunction and applied behavioral analytic (ABA) therapy. ...

Phase N/A

The Children’s Research Unit at Albert Einstein College of Medicine in the Bronx, New York is currently recruiting participants in the area for a genetic study of African Americans with autism. We are looking for children of all ages who identify as African American and have a diagnosis or are ...

Phase N/A

The study will look at the effect of balovaptan on social behavior and communication in people with autism spectrum disorder (ASD). It is a 24-week double-blind study followed by a two-year open-label extension.  

Phase

A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension.  This study will evaluate the efficacy, safety, and pharmacokinetics of 10 mg of oral administration balovaptan once a day (QD) compared with matching placebo in adults (18 years and older) with autism spectrum disorder (ASD). ...

Phase

This is a Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics of RO5285119 in children and adolescents aged 5-17 years with ASD who are high functioning (intelligence quotient [IQ] greater than or equal to [>=] 70). Enrollment will be staggered, ...

Phase

This is a Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics of RO5285119 in children and adolescents aged 5-17 years with ASD who are high functioning (intelligence quotient [IQ] greater than or equal to [≥] 70). Enrollment will be staggered, ...

Phase N/A

A DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED STUDY OF CM-AT FOR THE TREATMENT OF AUTISM IN CHILDREN WITH ALL LEVELS OF FECAL CHYMOTRYPSIN

Phase

The goal of the study is to learn how autism spectrum disorder influences the development of joint attention and shared engagement during infancy and toddler-hood. There is 1 study visit that lasts about 2 hours. There will be questionnaires, eye tracking and diffuse optical tomography (DOT) scan. Possible risks and ...

Phase N/A